Sign up for our Oncology Central weekly news round-up

Making an IMPAQTT on the quality of life of cancer patients


Christine Boers-Doets speaks to Francesca Lake, Managing Commissioning Editor: Christine underwent nursing training in The Netherlands. Currently, she is a PhD candidate, researcher and oncology clinical nurse specialist at the Department of Clinical Oncology at the Leiden University Medical Center (Leiden, The Netherlands). She is a member of the Board of Directors at the International Society of Oral Oncology; Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology alliance, and has acted as a consultant for companies including Amgen, Astra Zeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Eusa Pharma, GlaxoSmithKline, Merck Serono, Merck Sharp and Dohme, Nordic Pharma, Novartis, Pfizer, Roche, and Takeda. She is also the founder for the newly founded IMPAQTT FOUNDATION, and has her own company (IMPAQTT).

Click here to view full article.